CalciMedica, Inc.
CALC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534133
No open-market purchases or sales by CalciMedica, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $8.39M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in CalciMedica, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- −2 vs. Q4 2025
- Shares held
- 1.10M
- −2.11M (−65.8%) vs. Q4 2025
- Total value
- $592.5K
- −$20.6M (−97.2%) vs. Q4 2025
- New holders
- 11
- 4 more added
- Sold out
- 13
- 5 more reduced
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CALC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $8.39M |
| Q1 2026 | 27 | $592.5K |
| Q4 2025 | 31 | $24.2M |
| Q3 2025 | 31 | $10.9M |
| Q2 2025 | 30 | $5.93M |
| Q1 2025 | 30 | $7.49M |
| Q4 2024 | 29 | $15.1M |
| Q3 2024 | 24 | $13.6M |
| Q2 2024 | 21 | $11.8M |
| Q1 2024 | 20 | $14.8M |
| Q4 2023 | 12 | $1.49M |
| Q3 2023 | 13 | $1.56M |
| Q2 2023 | 13 | $2.72M |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 27 | $5.97M |
| Q3 2022 | 25 | $10.2M |
| Q2 2022 | 25 | $11.7M |
| Q1 2022 | 27 | $13.5M |
| Q4 2021 | 28 | $20.7M |
| Q3 2021 | 27 | $37.0M |
| Q2 2021 | 41 | $63.7M |
| Q1 2021 | 51 | $72.8M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding CalciMedica, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BNP Paribas Arbitrage, SA | 3 | $2 | 0.00% | −16−84.2% | Reduced |
| Wells Fargo & Company | 10 | $5 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 17 | $9 | 0.00% | −1,083−98.5% | Reduced |
| SBI Securities Co., Ltd. | 87 | $47 | 0.00% | −3−3.3% | Reduced |
| Advisor Group Holdings, Inc. | 107 | $58 | 0.00% | 00.0% | Unchanged |
| Brown Brothers Harriman & Co | 308 | $166 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,022 | $1.09K | 0.00% | +2,022 | New |
| Rockefeller Capital Management L.P. | 5,000 | $2.70K | 0.00% | −5,000−50.0% | Reduced |
| Sound View Wealth Advisors Group, LLC | 10,000 | $5.40K | 0.00% | −10,100−50.2% | Reduced |
| Ground Swell Capital, LLC | 12,307 | $6.65K | 0.01% | +12,307 | New |
| Northern Trust Corp | 12,530 | $6.77K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 12,816 | $6.92K | 0.00% | +12,816 | New |
| First Manhattan Co | 13,226 | $7.14K | 0.00% | 00.0% | Unchanged |
| TritonPoint Partners, LLC | 15,119 | $8.16K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 17,073 | $9.22K | 0.00% | +17,073 | New |
| Virtu Financial LLC | 17,895 | $10.0K | 0.00% | +17,895 | New |
| Gsa Capital Partners LLP | 23,777 | $13.0K | 0.00% | +23,777 | New |
| Susquehanna International Group, LLP | 30,716 | $16.6K | 0.00% | +30,716 | New |
| HRT Financial LP | 39,699 | $21.0K | 0.00% | +39,699 | New |
| Vanguard Fiduciary Trust Co | 45,829 | $24.7K | 0.00% | +45,829 | New |
| Stonehage Fleming Financial Services Holdings Ltd | 53,703 | $29.0K | 0.00% | 00.0% | Unchanged |
| Cambridge Investment Research Advisors, Inc. | 60,000 | $32.0K | 0.00% | +60,000 | New |
| Geode Capital Management, LLC | 123,382 | $66.7K | 0.00% | +23,595+23.6% | Added |
| 180 Wealth Advisors, LLC | 126,500 | $68.3K | 0.01% | +94,650+297.2% | Added |
| Renaissance Technologies LLC | 128,075 | $69.2K | 0.00% | +39,775+45.0% | Added |
| Vanguard Capital Management LLC | 169,110 | $91.3K | 0.00% | +169,110 | New |
| Jane Street Group, LLC | 178,515 | $96.4K | 0.00% | +159,312+829.6% | Added |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −1,300,000−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −683,904−100.0% | Sold out |
| Aisling Capital Management LP | 0 | $0 | 0.00% | −521,114−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −76,855−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −63,186−100.0% | Sold out |
| PVG Asset Management Corp | 0 | $0 | 0.00% | −45,830−100.0% | Sold out |
| Summit Financial, LLC | 0 | $0 | 0.00% | −35,484−100.0% | Sold out |
| Atria Investments LLC | 0 | $0 | 0.00% | −28,781−100.0% | Sold out |
| Timothy G. Youngquist 2020 Irrevocable Trust | 0 | $0 | 0.00% | −23,753−100.0% | Sold out |
| Cetera Investment Advisers | 0 | $0 | 0.00% | −22,290−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −18,900−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −14,855−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −9,027−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Meritage Portfolio Management | – | – | – | – | Not filed |